Anzeige
Mehr »
Donnerstag, 12.03.2026 - Börsentäglich über 12.000 News
Die nächsten 10.000 Bohrmeter könnten alles verändern, während andere Explorer noch planen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiSalesforce prices $25 billion debt offering for buyback
MiStifel reiterates Buy on TXO Energy stock after asset sale
MiAccenture expands Google Cloud partnership for AI cyber defense
MiCalifornia Resources prices $350M senior notes offering
MiSonida Q4 2025 slides: $1.8B merger creates top-10 senior housing owner
MiOppenheimer reiterates Biogen stock rating on SMA drug data
MiWilliam Blair reiterates Outperform on AppLovin stock after investor meeting
MiWSP Global prices $1.5 billion senior notes offering
MiGlobalFoundries shareholder launches 20M share offering
MiPacira BioSciences responds to DOMA director nominations
MiBaker Hughes issues $9.5 billion debt to fund Chart acquisition
MiViking takes delivery of new 190-guest river cruise ship
MiJoby begins flight testing first FAA-conforming air taxi aircraft
MiRaymond James reiterates Market Perform on Echostar stock
MiStifel reiterates Forward Air stock rating as strategic review nears end
MiWeyerhaeuser stock rating reaffirmed at Outperform by RBC Capital
MiVerastem stock initiated at Buy by BTIG with $19 price target
MiWolfe Research reiterates Outperform on Via Transportation stock
MiImmunitybio stock initiated at Buy by BTIG with $13 target
MiBTIG initiates Ascentage Pharma stock coverage with buy rating
MiInnate Pharma stock initiated with buy rating at BTIG on oncology pipeline
MiStifel comments on Papa John's stock after takeover offer report
MiFreedom Capital Markets initiates Rush Street Interactive stock with buy rating
MiVictory Capital criticizes Janus Henderson special committee
MiOppenheimer reiterates Sagimet stock rating on MASH trial progress